BioSpace News Archive

Can-Fite BioPharma Ltd. announced the Company’s CEO Dr. Pnina Fishman will present at the H. C. Wainwright 21st Annual Global Investment Conference to be held on September 8-10, 2019 at the Lotte New York Palace Hotel in New York City.

With over 160 partners worldwide, the SCIEX Channel Partner Portal Program is designed to better serve customers, help generate business and provide reliable, sensitive and intuitive solutions for routine and complex analysis

MX3 Diagnostics announced that it has been designated the official hydration diagnostics partner for the IRONMAN Oceania Series.

Biopharmaceutical company to unify quality management on a single platform for greater efficiency and compliance

PathoQuest announces the closing of an 8M euros financing series.

Achieve Life Sciences, Inc. announced the Company will host its first investor day on Friday, September 20, 2019 in New York City.

Exclusive editorial project covers the U.S., Asia, Africa and the Middle East

AbCellera announced the expansion of its executive team with the hiring of Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel.

Files Form 10-K for the Fiscal Year Ended December 31, 2018 and Form 10-Q for the Fiscal Quarters Ended March 31, 2019 and June 30, 2019

NOBLES MEDICAL TECHNOLOGIES II, INC. (NMT2) ANNOUNCED TODAY THE APPROVAL BY THE U.S. FDA OF ITS IDE OF NOBLESTITCH™ EL FOR PFO CLOSURE FOR REDUCTION OF RECURRENT ISCHEMIC STROKE [05-September-2019] FOUNTAIN VALLEY, Calif. , Sept. 5, 2019 /PRNewswire/ -- Nobles Medical Technologies II has received approval from the U.S. Food and Drug Administration (USFDA) to conduct a